Lung cancer in patients with idiopathic pulmonary fibrosis
- PMID: 11491167
- DOI: 10.1183/09031936.01.99055301
Lung cancer in patients with idiopathic pulmonary fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) was reported to be associated with increased risk of lung cancer as a result of the occurrence of atypical or dysplastic epithelial changes in fibrosis which progressed to invasive malignancy. In that situation, the cancer will develop in the area of major fibrosis. To investigate the direct relationship between fibrosis and cancer development, the real concordance rate of the two lesions in the chest computed tomography (CT) was analysed and compared to the histological types of lung cancer. The subjects included 63 patients with combined lung cancer and IPF (IPF-CA), 218 patients with lone IPF, and 2,660 patients with primary lung cancer. All patients were diagnosed at Asan Medical Center during the same period. The age, percentage of smokers, and the male sex were significantly higher in IPF-CA compared with lone IPF. The odds ratio of smoking was 2.71 compared to nonsmoking IPF controls. In IPF-CA, 56% of the cancer was located in the periphery of the lung and 52% in the upper lobe. The majority of the cancers (64%) were found in the nonfibrotic area at chest CT. The most frequent cell type was squamous cell carcinoma (35%), and there was no significant difference in the cancer cell type between IPF-CA and total lung cancer population. These findings suggest that in combined lung cancer and idiopathic pulmonary fibrosis patients, the features of the lung cancer are similar to the total lung cancer population.
Similar articles
-
Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis.Lung. 2015 Feb;193(1):71-7. doi: 10.1007/s00408-014-9664-8. Epub 2014 Nov 9. Lung. 2015. PMID: 25381634
-
Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings.J Comput Assist Tomogr. 1996 Nov-Dec;20(6):979-82. doi: 10.1097/00004728-199611000-00020. J Comput Assist Tomogr. 1996. PMID: 8933802
-
Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.Respir Med. 2014 Oct;108(10):1549-55. doi: 10.1016/j.rmed.2014.07.020. Epub 2014 Aug 15. Respir Med. 2014. PMID: 25175479
-
Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese cases.Chest. 1995 Nov;108(5):1272-7. doi: 10.1378/chest.108.5.1272. Chest. 1995. PMID: 7587428 Review.
-
Idiopathic pulmonary fibrosis will increase the risk of lung cancer.Chin Med J (Engl). 2014;127(17):3142-9. Chin Med J (Engl). 2014. PMID: 25189961 Review.
Cited by
-
Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer.Int J Clin Oncol. 2014 Apr;19(2):266-73. doi: 10.1007/s10147-013-0566-1. Epub 2013 May 10. Int J Clin Oncol. 2014. PMID: 23660786
-
Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?Int J Mol Sci. 2022 Jan 4;23(1):546. doi: 10.3390/ijms23010546. Int J Mol Sci. 2022. PMID: 35008971 Free PMC article. Review.
-
Postoperative Acute Exacerbation of IPF after Lung Resection for Primary Lung Cancer.Pulm Med. 2011;2011:960316. doi: 10.1155/2011/960316. Epub 2011 Feb 7. Pulm Med. 2011. PMID: 21637373 Free PMC article.
-
Understanding cancer etiology: A review of the evidence-based Ayurvedic framework of cancer etiologies.Ayu. 2022 Jan-Mar;43(1):1-7. doi: 10.4103/ayu.ayu_318_21. Epub 2023 Jun 24. Ayu. 2022. PMID: 37554416 Free PMC article. Review.
-
The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.Intern Med. 2018 Jul 1;57(13):1827-1832. doi: 10.2169/internalmedicine.0404-17. Epub 2018 Feb 9. Intern Med. 2018. PMID: 29434143 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical